Mix-and-match booster shots a plus for long-term care, AHCA/NCAL’s chief doc says
By
Alicia Lasek
Oct 25, 2021
Adding the Moderna and Johnson & Johnson vaccines to the mix will “catapult” efforts to increase COVID-19 booster access for residents and staff, David Gifford, M.D., says.
CMS shares LTC booster data; coverage among residents meets national average
By
Alicia Lasek
Feb 10, 2022
Nursing home booster vaccination data is now available on the Medicare.gov Care Compare website as part of CMS’s effort to help increase facility vaccination coverage, the agency said Wednesday.
Low vaccination levels explain high COVID burden on the socially vulnerable: study
By
Alicia Lasek
Apr 06, 2023
Vaccination coverage remains lower in socially vulnerable communities, contributing to relatively poor COVID-19 outcomes, investigators report.
FDA proposes two annual COVID shots for seniors in ‘simplified’ vaccine schedule
By
Alicia Lasek
Jan 24, 2023
In an effort to streamline COVID-19 protection, older adults and others vulnerable to severe disease would receive two annual shots of an updated vaccine, according to a plan to be evaluated on Thursday...
Clinical briefs for Monday, Sept. 20
By
Alicia Lasek
Sep 20, 2021
CNAs remain least vaccinated, requiring ‘large-scale’ solution … AARP says Florida leads nation in COVID deaths of nursing home residents, staff … Hardware-free virtual physical therapy system...
Supreme Court won’t review healthcare workers’ challenge to Maine vaccine mandate
By
Alicia Lasek
Feb 23, 2022
The U.S. Supreme Court has declined to hear arguments in a lawsuit that would allow healthcare workers to apply for religious exemptions to Maine’s COVID-19 vaccine mandate.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
CDC may be overestimating COVID-19 vaccination stats for older adults, state officials and experts say
By
Alicia Lasek
Dec 13, 2021
The agency’s online tracker currently shows that 99.9% of U.S. seniors have been at least partly vaccinated against COVID-19. But this sky-high figure is almost certainly not accurate, observers...
CDC safety panel: J&J vaccine benefits outweigh rare neuro risks seen in older adults
By
Alicia Lasek
Jul 26, 2021
The benefits of the shot — including reduced hospitalization, intensive care unit admission and death — outweigh the risk of contracting Guillain-Barre syndrome, the Advisory Committee on Immunization...